Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Jiachen Xu
Observed name:
J. Xu
Institution:
The Fourth Affiliated Hospital of Soochow University (Suzhou Dushu Lake Hospital)
Observed institutions:
Jinggangshan University,
First Affiliated Hospital of Soochow University,
The Fourth Affiliated Hospital of Soochow University (Suzhou Dushu Lake Hospital)
ORCID:
0000-0002-3865-5315
Observed ORCID:
0000-0002-3865-5315
OpenAlex ID:
A5102994780
Prevalence of sarcopenia and its association with clinical outcomes in heart failure: An updated meta‐analysis and systematic review
2023
·
Ruzhao Chen
, Jiachen Xu
, et al.
·
Clinical Cardiology
·
85
PDF
Sarcopenia as a Risk Factor for Future Hip Fracture: A Meta-Analysis of Prospective Cohort Studies
2020
·
P. Huang
, K. Luo
, et al.
·
The journal of nutrition health & aging
·
63
Magnesium microspheres for enhanced transarterial chemoembolization therapy of hepatocellular carcinoma: From animal models to a pilot clinical study
2025
·
Fei Gong
, Liyun Zheng
, et al.
·
Science Advances
·
32
Modified quantitative and volumetric response evaluation criteria for patients with hepatocellular carcinoma after transarterial chemoembolization
2023
·
Jiachen Xu
, Yu Yin
, et al.
·
Frontiers in Oncology
·
8
PDF
Dual-targeted microspheres reshape the metabolic-immune microenvironment to reverse post-embolization dilemmas in hepatocellular carcinoma
2026
·
Nan Jiang
, Zifan Pei
, et al.
·
Cell Reports Medicine
·
3
Re: “Hepatic Artery Infusion Chemotherapy Using Fluorouracil, Leucovorin, and Oxaliplatin versus Transarterial Chemoembolization as Initial Treatment for Locally Advanced Hepatocellular Carcinoma: A Propensity Score–Matching Analysis”
2021
·
Jiachen Xu
, Caifang Ni
·
Journal of Vascular and Interventional Radiology
Show more works
View as search
Works count:
6
Citation count:
191
H-index:
4
I10-index:
3
Year
Topic
Type